Table 1 Demographic data and clinical characteristics
From: Mortality in patients with interstitial lung diseases hospitalized by severe or critical COVID-19
Variable | ILD with COVID-19 (n = 41) | COVID-19 (n = 82) | P-value |
|---|---|---|---|
Age, years, IQR | 65 (57–75) | 64 (59–72) | 0.8 |
Gender, women (%) | 27 (65) | 27 (33) | 0.0005 |
BMI (kg/m2), IQR | 27 | 28 (25—32) | 0.3 |
Type 2 diabetes, (%) | 8 (20) | 25 (30) | 0.13 |
Systemic high blood pressure (%) | 14 (34) | 32 (39) | 0.3 |
Smoking status (%) | 14 (34) | 24 (29) | 0.3 |
Complete vaccination (%) | 6 (14) | 7 (9) | 0.2 |
Oxygen saturation at rest, IQR | 71 (62–85) | 65 (54—80) | 0.13 |
Days of evolution, IQR | 10 (6–15) | 10 (7—13) | 0.7 |
Leukocytes absolute number (10^3/mm3), IQR | 9 (6–12) | 11 (8—14) | 0.01 |
Neutrophiles absolute number (10^3/mm3), IQR | 8 (5–10) | 10 (6—12) | 0.02 |
Lymphocytes absolute number (10^3/mm3), IQR | 0.8 (0.3–1) | 0.8 (0.5—1) | 0.1 |
CRP (mg/dL), IQR | 15 (8–22) | 19 (11—25) | 0.06 |
Procalcitonin (ng/dL), IQR | 0.6 (0.06–0.4) | 0.7 (0.1—0.5) | 0.09 |
Ferritin (ng/dL), IQR | 1246 (445–1687) | 1592 (588—2202) | 0.1 |
Fibrinogen (mg/dL), IQR | 639 (472–750) | 698 (600–750) | 0.1 |
D-Dimer (μg/mL), IQR | 3.6 (0.6–3.7) | 4 (0.7–3) | 0.9 |